Difference between revisions of "Hysterectomy for endometrial cancer grossing"
Jump to navigation
Jump to search
| Line 72: | Line 72: | ||
===Protocol notes=== | ===Protocol notes=== | ||
In [[BRCA|BRCA1 mutation or BRCA2 mutation carriers]], the ovaries and tubes should be [[submitted in total]].<ref name=pmid24495259>{{Cite journal | last1 = Downes | first1 = MR. | last2 = Allo | first2 = G. | last3 = McCluggage | first3 = WG. | last4 = Sy | first4 = K. | last5 = Ferguson | first5 = SE. | last6 = Aronson | first6 = M. | last7 = Pollett | first7 = A. | last8 = Gallinger | first8 = S. | last9 = Bilbily | first9 = E. | title = Review of findings in prophylactic gynaecological specimens in Lynch syndrome with literature review and recommendations for grossing. | journal = Histopathology | volume = 65 | issue = 2 | pages = 228-39 | month = Aug | year = 2014 | doi = 10.1111/his.12386 | PMID = 24495259 }}</ref> | |||
===Alternate approaches=== | ===Alternate approaches=== | ||
Revision as of 19:52, 6 June 2018
The protocol is for grossing a hysterectomy for endometrial cancer.
Hysterectomies with endometrial hyperplasia are dealt with in the hysterectomy for hyperplasia protocol.
Introduction
This is a very common procedure as endometrial cancer.
Protocol
Specimen:
- Hysterectomy for endometrial cancer.
External measures:
- Uterus and cervix: ___x___x___cm
- Specimen mass: ____grams.
- Left ovary: ___x___x___cm.
- Left fallopian tube ___x___cm.
- Right ovary: ___x___x___cm.
- Right fallopian tube: ___x___cm.
- Exocervix: ___cm.
- Cervical os: ___cm, round/slit-like, probe patent.
Appearance:
- Shape: [pear-shaped/distorted].
- Serosal surface: [smooth, shiny, powder-burn lesions].
- Serosa nodules/lesion/mass: [none, present ___cm in greatest dimension].
- Ectocervix: tan-white glistening.
- Left ovary: [unremarkable / atrophic / cortical cysts].
- Left fallopian tube: [unremarkable / paratubal cysts].
- Right ovary: [unremarkable / atrophic / cortical cysts].
- Right fallopian tube: [unremarkable / paratubal cysts].
Internal measures:
- Endometrial cavity: ____x____cm.
- Myometrial wall thickness (maximum): ____cm.
Tumour:
- Dimension: ___x___x___cm.
- Location: [fundus/body, involves anterior and/or posterior wall, lower uterine segment, cervix].
- Appearance: [ill-defined, soft, friable, polypoid-shape, tan-white].
- Maximum depth of invasion: ___cm.
- Myometrial thickness: ___cm.
- Grossly normal endometrium - maximum thickness: ___cm.
Other findings:
- Myometrial tumour(s):
- Location: intramural / subserosal.
- Appearance: white, firm, whorled.
- Size range: ___-___cm in greatest dimension.
- Other features:
- Hemorrhage: absent.
- Necrosis: absent.
Inking code:
- Green - anterior serosa.
- Black - posterior serosa.
Representative sections:
- Anterior cervix.
- Anterior lower uterine segment.
- Posterior cervix.
- Posterior lower uterine segment.
- Tumour and anterior endomyometrium with greatest depth of invasion, full thickness sections [submit two full thickness section of deepest invasion from each involved wall of the myometrium with inked serosa].
- Tumour and posterior endomyometrium with greatest depth of invasion, full thickness sections.
- Additional sections of the tumour [for a total of at least one section/cm of tumour].
- Section of firm whorled tan nodules in anterior/posterior myometrium.
- Any other lesions.
- Right ovary.
- Right fallopian tube [fimbria submitted entirely].
- Left ovary.
- Left fallopian tube [fimbria submitted entirely].
Protocol notes
In BRCA1 mutation or BRCA2 mutation carriers, the ovaries and tubes should be submitted in total.[1]
Alternate approaches
See also
Related protocols
References
External links
- ↑ Downes, MR.; Allo, G.; McCluggage, WG.; Sy, K.; Ferguson, SE.; Aronson, M.; Pollett, A.; Gallinger, S. et al. (Aug 2014). "Review of findings in prophylactic gynaecological specimens in Lynch syndrome with literature review and recommendations for grossing.". Histopathology 65 (2): 228-39. doi:10.1111/his.12386. PMID 24495259.